PATENT CLAIM ANALYSIS

Application Number: 15752635
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["514", "265100"]

Abstract:
Janus kinase 1 selective inhibitors and pharmaceutical use thereof are provided.

Claim (Index 3):
A compound of Formula 2, or a pharmaceutically acceptable salt, solvate, or stereoisomer thereof, wherein, in Formula 2, X is nitrogen or oxygen, --- is a single bond when X is nitrogen, or is absent when X is oxygen, and R 1  is methyl, R 2  is 1-(2-cyanoacetyl)piperidine-4-yl, 1-(phenylsulfonyl)piperidine-4-yl, 1-(3-cyanophenylsulfonyl)piperidine-4-yl, 1-(2-cyanoacetyl)piperidine-3-yl, 1-(3-cyanophenylsulfonyl)piperidine-3-yl, 1-(3-cyanophenylsulfonyl)-4-methyl-piperidine-3-yl, 1-(2-cyanoacetyl)-3,3-dimethylpyrrolidine-4-yl, [1-(2-cyanoacetyl)piperidine-3-yl]methyl, or [1-(3-cyanophenylsulfonyl)piperidine-3-yl]methyl, or R 1  and R 2 , together with X, form 6-(2-cyanoacetyl)octahydro-6H-pyrrolo-[3,4-b]pyridine-1-yl.

Metadata:
- Claim Count in Document: 35.0
- Percentile: 88.0
- Lexical Diversity: 1.0
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15507409', '14183946', '13928696', '14715046', '13859569']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.784160066442929
- 35 USC 102 Novelty (BERT): 0.559084577714501
- Combined Prediction Score: 0.7616525175700862
- Mean Citation Score: 368.18293400000016
- Max Citation Score: 425.25983
- Similarity Product: 323.4017672809076

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test